JACQUELINE ALLEN: Open Payments
NPI 1730578121 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 33 payments from 13 companies in 2025. Trend: 2023 $363 · 2024 $860 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 8 | $123 |
| Janssen Pharmaceuticals, Inc | 5 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Alkermes, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $26 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Azstarys, COBENFY, Auvelity, ARISTADA, SPRAVATO, INVEGA SUSTENNA, TRINTELLIX, QULIPTA.
Industry payments across KY — which companies pay providers there.
